Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives.

Cancers (Basel) · 2020 · PMC7409174 · PMID 32674264

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a mild trendno p-value reported

In this proof-of-concept study, a mild trend for reduced tumor volumes was observed when AAV vectors expressing anti-PD-1 scFv were combined with chemotherapy [ 189 ].

also in 257 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.